119 related articles for article (PubMed ID: 28089594)
1. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer.
Lin YT; Liu YN; Wu SG; Yang JC; Shih JY
Clin Lung Cancer; 2017 May; 18(3):324-332.e1. PubMed ID: 28089594
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Clinical Characteristics and Prognosis of Advanced Non-Small Cell Lung Cancer with Exon 20 Insertions.
Wang H; Xu Y; Lin J; Huang Y
Cancer Control; 2024; 31():10732748241262190. PubMed ID: 38857163
[TBL] [Abstract][Full Text] [Related]
3. Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion.
Hamada A; Suda K; Nishino M; Obata K; Oiki H; Fukami T; Fukuda S; Fujino T; Ohara S; Koga T; Chiba M; Shimoji M; Ito M; Takemoto T; Soh J; Tsutani Y; Mitsudomi T
J Thorac Oncol; 2024 Jan; 19(1):71-79. PubMed ID: 37666482
[TBL] [Abstract][Full Text] [Related]
4. Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations.
Hu M; Zhong C; Wang J; Chen J; Zhou T
Front Immunol; 2024; 15():1399975. PubMed ID: 38774882
[TBL] [Abstract][Full Text] [Related]
5. EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical Scenarios.
Kobayashi IS; Viray H; Rangachari D; Kobayashi SS; Costa DB
Cells; 2021 Dec; 10(12):. PubMed ID: 34944068
[No Abstract] [Full Text] [Related]
6. A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments.
Zwierenga F; van Veggel BAMH; van den Berg A; Groen HJM; Zhang L; Groves MR; Kok K; Smit EF; Hiltermann TJN; de Langen AJ; van der Wekken AJ
Cancer Treat Rev; 2023 Nov; 120():102628. PubMed ID: 37797348
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non-small cell lung cancer.
Pan B; Liang J; Shi H; Rao K; Guo W; Zhan C
Thorac Cancer; 2023 Nov; 14(33):3247-3258. PubMed ID: 37795778
[TBL] [Abstract][Full Text] [Related]
8. Advances in the Diagnosis and Treatment of Advanced Non-Small-Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.
Liu J; Xiang Y; Fang T; Zeng L; Sun A; Lin Y; Lu K
Clin Lung Cancer; 2024 Mar; 25(2):100-108. PubMed ID: 38172024
[TBL] [Abstract][Full Text] [Related]
9. [Advances in Treatment of Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations].
Yang X; Zhao J
Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):337-350. PubMed ID: 35599009
[TBL] [Abstract][Full Text] [Related]
10. EGFR exon20 insertion mutations in non-small cell lung cancer: Clinical implications and recent advances in targeted therapies.
Bai Q; Wang J; Zhou X
Cancer Treat Rev; 2023 Nov; 120():102605. PubMed ID: 37703723
[TBL] [Abstract][Full Text] [Related]
11. [Progress in Detection of EGFR Exon 20 Insertion Mutation and Targeted Therapies
in Non-small Cell Lung Cancer].
Wang Y; Chu T
Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):135-147. PubMed ID: 36872052
[TBL] [Abstract][Full Text] [Related]
12. Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications.
Marchetti A; Del Grammastro M; Filice G; Felicioni L; Rossi G; Graziano P; Sartori G; Leone A; Malatesta S; Iacono M; Guetti L; Viola P; Mucilli F; Cuccurullo F; Buttitta F
PLoS One; 2012; 7(7):e42164. PubMed ID: 22848739
[TBL] [Abstract][Full Text] [Related]
13. Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.
Ihle MA; Heydt C; Schultheis AM; Stöhr R; Haller F; Herold S; Aust D; Dietmaier W; Evert M; Eszlinger M; Haak A; Laßmann S; Vorholt D; Breitenbücher F; Werner M; Streubel A; Mairinger T; Grassow-Narlik M; Merkelbach-Bruse S
Sci Rep; 2024 Jun; 14(1):13069. PubMed ID: 38844820
[TBL] [Abstract][Full Text] [Related]
14. [Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)].
Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
Zhongguo Fei Ai Za Zhi; 2023 May; 26(5):325-337. PubMed ID: 37316442
[TBL] [Abstract][Full Text] [Related]
15. Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasets.
Viteri S; Minchom A; Bazhenova L; Ou SI; Bauml JM; Shell SA; Schaffer M; Gu J; Rose JB; Curtin JC; Mahadevia P; Girard N
Mol Oncol; 2023 Feb; 17(2):230-237. PubMed ID: 36269676
[TBL] [Abstract][Full Text] [Related]
16. EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy.
Chelabi S; Mignard X; Leroy K; Monnet I; Brosseau S; Theou-Anton N; Massiani MA; Friard S; Duchemann B; Fabre E; Giroux-Leprieur E; Cadranel J; Wislez M
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680280
[TBL] [Abstract][Full Text] [Related]
17. EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives.
Hou J; Li H; Ma S; He Z; Yang S; Hao L; Zhou H; Zhang Z; Han J; Wang L; Wang Q
Biomark Res; 2022 Apr; 10(1):21. PubMed ID: 35418149
[TBL] [Abstract][Full Text] [Related]
18. Exons 19 and 21 of epidermal growth factor receptor are highly conserved in squamous cell cancer of the head and neck.
Carlson M; Wuertz B; Lin J; Taylor R; Ondrey F
Int J Otolaryngol; 2009; 2009():649615. PubMed ID: 20130810
[TBL] [Abstract][Full Text] [Related]
19. Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine.
Park J; Lee B; Song JY; Sung M; Kwon MJ; Kim CR; Lee S; Shin YK; Choi YL
Pathology; 2024 May; ():. PubMed ID: 38811262
[TBL] [Abstract][Full Text] [Related]
20. Mobocertinib and Bevacizumab for Amivantamab-Refractory Lung Cancer With
Kim J; Lee Y
JTO Clin Res Rep; 2023 Dec; 4(12):100600. PubMed ID: 38124788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
